299 related articles for article (PubMed ID: 16960831)
1. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
Gao H; Wang YN; Fan YG; Ma JB
J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system.
Gao H; Wang YN; Fan YG; Ma JB
J Control Release; 2005 Sep; 107(1):158-73. PubMed ID: 16095747
[TBL] [Abstract][Full Text] [Related]
3. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
4. Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(beta-cyclodextrin)s and their nanoparticles as protein delivery systems.
Gao H; Yang YW; Fan YG; Ma JB
J Control Release; 2006 May; 112(3):301-11. PubMed ID: 16616967
[TBL] [Abstract][Full Text] [Related]
5. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
[TBL] [Abstract][Full Text] [Related]
7. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel.
Liu SQ; Tong YW; Yang YY
Mol Biosyst; 2005 Jul; 1(2):158-65. PubMed ID: 16880979
[TBL] [Abstract][Full Text] [Related]
8. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
11. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.
Cai C; Bakowsky U; Rytting E; Schaper AK; Kissel T
Eur J Pharm Biopharm; 2008 May; 69(1):31-42. PubMed ID: 18023160
[TBL] [Abstract][Full Text] [Related]
12. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
Gvili K; Benny O; Danino D; Machluf M
Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
[TBL] [Abstract][Full Text] [Related]
13. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
14. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.
Cheng FY; Wang SP; Su CH; Tsai TL; Wu PC; Shieh DB; Chen JH; Hsieh PC; Yeh CS
Biomaterials; 2008 May; 29(13):2104-12. PubMed ID: 18276001
[TBL] [Abstract][Full Text] [Related]
15. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
17. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
18. Interactions of some modified mono- and bis-beta-cyclodextrins with bovine serum albumin.
Gao H; Wang YN; Fan YG; Ma JB
Bioorg Med Chem; 2006 Jan; 14(1):131-7. PubMed ID: 16183293
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
